by Mark Curtis | Oct 17, 2013
. Welcome to the first Regenerative Medicine Deal Review, an overview of recent licensing, partnering, and financing activity all exclusively in the regenerative medicine and cell therapy industries. Like my first post ‘Update from the Clinic’, this piece is intended...
by Angela C. H. McDonald | Oct 16, 2013
> This week, while perusing my favourite news websites, I discovered that October is Down Syndrome Awareness month in the US. We Canadians however, have reserved our Down Syndrome Awareness week for the first week of November but nevertheless, this got me thinking...
by Ben Paylor | Oct 11, 2013
“Stem cell research is going to impact on the lives of all Canadians as we move to an era of new stem cell-based treatments for degenerative diseases. StemCellShorts helps to engage the public in understanding the science of stem cells and I have been delighted to be...
by Holly Wobma | Oct 9, 2013
> For anyone following the celebrity gossip of the stem cell field, you’ve probably come across one of our rising stars, the induced pluripotent stem cell (iPSC). Award winning and deemed to have loads of potential, each one of us can produce this type of cell. The...
by Mark Curtis | Oct 3, 2013
. I have recently joined the business development group at CCRM, as an analyst, and believe it would be useful to start compiling some recaps on clinical developments in the regenerative medicine (RM) and cell therapy industries to complement the other science-related...
by Ben Paylor | Sep 27, 2013
> Welcome to the official launch of the first StemCellShorts video: “What is a stem cell?” narrated by stem cell research great Dr. Jim Till. Join us again on October 11 and 25 for the online premieres of two more videos in the series. Anyone who has spent time...
Comments